Samples of hepatocellular cancer (>5 cm) are considered stage T3-T4 tumors, and samples (<5 cm) are considered stage T1-T2 tumors [22]; 234 samples were stage T1-T2 tumors,172 samples were stage T3-T4 tumors, and the proportion of FOXC1-positive tumors in each group was 58.1% (136/234) and 70.3% (121/172), respectively (Figure 2). Here, FOXC1 is linked to hepatocellular carcinoma.